Also, poor prognosis of patients with endometrial cancer is associated with higher levels of HOXA4, HOX5, HOXA6, HOXA7, and HOXB9 expression, whereas favorable prognosis of patients with endometrial cancer is associated with higher levels of HOXB5 and HOXB6 expression. Here, HOXB9 is linked to endometrial cancer.